Graphene phosphoprotein hybrid synaptic interfaces: engineering disease-specific plasticity restoration in Alzheimer’s and Parkinson’s models

Synaptic dysfunction is an important early feature of Alzheimer’s disease (AD) and Parkinson’s disease (PD), in which impaired long-term potentiation (LTP), long-term depression (LTD) and metaplasticity accompany disturbances in postsynaptic phosphosignalling. Neuroproteomic studies implicate receptor phosphorylation, kinase–phosphatase imbalance, cytoskeletal remodelling and neuromodulator-dependent pathways in these deficits. Alongside the NMDAR–CaMKII–PSD-95 axis, acetylcholine- and glutamate-regulated small-GTPase cascades provide mechanistic links between biochemical signalling and dendritic spine plasticity. Advances in graphene-based neuromorphic devices demonstrate programmable conductance states and electrical analogues of synaptic learning, suggesting a possible engineering framework informed by molecular disease signatures. This narrative review critically examines synaptic phosphoproteomic alterations in AD and PD, their implications for designing phosphoprotein-functionalised graphene interfaces, and the conceptual integration of glutamatergic and neuromodulatory inputs into device operation. Importantly, electronic emulation of LTP/LTD has not established restoration of endogenous phosphorylation networks, synaptic incorporation or therapeutic efficacy in AD or PD. We distinguish demonstrated molecular and materials findings from the proposed biochemical-to-electronic coupling mechanisms and discuss the experimental, biological and translational limitations that must be resolved before disease-specific synaptic repair can be evaluated.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular Neuroscience
Published
2026-11-18
DOI
https://doi.org/10.3389/fncel.2026.1892324
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Graphene phosphoprotein hybrid synaptic interfaces: engineering disease-specific plasticity restoration in Alzheimer’s and Parkinson’s models

Vandana Sadananda, Chigateri M. Vinay, Thottethodi Subrahmanya Keshava Prasad, Bhat Gowrish S.
2 links
Frontiers in Cellular Neuroscience
Neuroscience and Neuropharmacology Research
article

Graphene phosphoprotein hybrid synaptic interfaces: engineering disease-specific plasticity restoration in Alzheimer’s and Parkinson’s models

Vandana Sadananda, Chigateri M. Vinay, Thottethodi Subrahmanya Keshava Prasad, Bhat Gowrish S.
article en

Abstract

Synaptic dysfunction is an important early feature of Alzheimer’s disease (AD) and Parkinson’s disease (PD), in which impaired long-term potentiation (LTP), long-term depression (LTD) and metaplasticity accompany disturbances in postsynaptic phosphosignalling. Neuroproteomic studies implicate receptor phosphorylation, kinase–phosphatase imbalance, cytoskeletal remodelling and neuromodulator-dependent pathways in these deficits. Alongside the NMDAR–CaMKII–PSD-95 axis, acetylcholine- and glutamate-regulated small-GTPase cascades provide mechanistic links between biochemical signalling and dendritic spine plasticity. Advances in graphene-based neuromorphic devices demonstrate programmable conductance states and electrical analogues of synaptic learning, suggesting a possible engineering framework informed by molecular disease signatures. This narrative review critically examines synaptic phosphoproteomic alterations in AD and PD, their implications for designing phosphoprotein-functionalised graphene interfaces, and the conceptual integration of glutamatergic and neuromodulatory inputs into device operation. Importantly, electronic emulation of LTP/LTD has not established restoration of endogenous phosphorylation networks, synaptic incorporation or therapeutic efficacy in AD or PD. We distinguish demonstrated molecular and materials findings from the proposed biochemical-to-electronic coupling mechanisms and discuss the experimental, biological and translational limitations that must be resolved before disease-specific synaptic repair can be evaluated.

Frontiers in Cellular NeuroscienceVol. 20
Nitte University (IN), Ramaiah Institute of Technology (IN), K S Hegde Medical Academy (IN)
Indian Council of Medical Research
Good health and well-being
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon